Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 31, Issue Suppl 1
5PSQ-076 Efficacy and safety of nivolumab monotherapy vs nivolumab plus ipilimumab in renal cell carcinoma in clinical practice
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Section 5: Patient safety and quality assurance
5PSQ-076 Efficacy and safety of nivolumab monotherapy vs nivolumab plus ipilimumab in renal cell carcinoma in clinical practice
Free
Online download statistics by month:
Online download statistics by month: March 2024 to October 2024
Abstract
Full
Pdf
Mar 2024
31
0
11
Apr 2024
44
0
5
May 2024
28
0
2
Jun 2024
15
0
1
Jul 2024
25
0
4
Aug 2024
4
0
1
Sep 2024
13
0
0
Oct 2024
10
0
1
Total
170
0
25
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF